BEST DIGITAL NEWS START-UP, WAN-IFRA 2019 GOLD AWARD

BioNTech raises US$250m from investors including Temasek

BioNTech raises US$250m from investors including Temasek

1 -min read
Listen to this article
1 -min read
Listen to this article

[FRANKFURT] BioNTech said Singapore's investment company Temasek and other investors are injecting US$250 million into the German biotech firm through a private placement.

The company, which is developing a Covid-19 vaccine, said the transaction includes the purchase of about US$139 million in ordinary shares and a US$112 million investment in four-year mandatory convertible notes.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes